Efficacy of Music Therapy Protocols for Burn Debridement

The Efficacy of Music Therapy Protocols for Decreasing Pain, Anxiety, and Muscle Tension Levels During Burn Debridement: A Prospective Randomized Crossover Trial

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00822497

Acronym

MTS1

Enrollment

Registered

2009-01-14

Start date

2004-10-31

Completion date

2010-07-31

Last updated

2010-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management

Keywords

music therapy, pain, anxiety, muscle tension

Brief summary

The purpose of this prospective, crossover randomized study is to explore the efficacy of two music therapy protocols on pain, anxiety, and muscle tension levels throughout the debridement process in individuals hospitalized with moderate to severe burns.

Detailed description

The study is a prospective, randomized crossover clinical trial conducted on a 14-bed inpatient comprehensive burn care center. The purpose of this study is to investigate the efficacy of Music-Based Imagery (MBI) and Music Alternate Engagement (MAE) for pain and anxiety management for burn patients throughout the debridement process.

Interventions

BEHAVIORALMusic-Based Imagery (MBI)

MBI is form of music-assisted relaxation with imagery. This protocol is used at the patients' bedside before and after the debridement process.

BEHAVIORALMusic Alternate Engagement (MAE)

MAE consisted of a menu of music therapy interventions aimed at engaging the patients in music and diverting them away from the debridement process.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

7 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient is admitted for at least three days (excluding day of admission) * Patient is at least seven years old * Patient is able to communicate, i.e. awake and alert * Patient is oriented

Exclusion criteria

* Patient admitted for/less than three days * Patient under seven years of age * Patient not able to communicate, i.e. sedated and/or intubated * Patient is not oriented, i.e. active psychosis, hallucinations, delusions, late-stage Alzheimer's or dementia diagnoses

Design outcomes

Primary

Measure	Time frame
Pain, Anxiety, Muscle Tension levels	7 data points before, during, after debridement

Secondary

Measure	Time frame
Narcotics & Anxiolytics (dosage)	Throughout debridement process

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026